BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 26078812)

  • 1. Transforming Growth Factor-Beta and Oxidative Stress Interplay: Implications in Tumorigenesis and Cancer Progression.
    Krstić J; Trivanović D; Mojsilović S; Santibanez JF
    Oxid Med Cell Longev; 2015; 2015():654594. PubMed ID: 26078812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between Oxidative Stress and Transforming Growth Factor-Beta in Cancers.
    Chung J; Huda MN; Shin Y; Han S; Akter S; Kang I; Ha J; Choe W; Choi TG; Kim SS
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34947978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progression of genotype-specific oral cancer leads to senescence of cancer-associated fibroblasts and is mediated by oxidative stress and TGF-β.
    Hassona Y; Cirillo N; Lim KP; Herman A; Mellone M; Thomas GJ; Pitiyage GN; Parkinson EK; Prime SS
    Carcinogenesis; 2013 Jun; 34(6):1286-95. PubMed ID: 23358854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IFNγ induces oxidative stress, DNA damage and tumor cell senescence via TGFβ/SMAD signaling-dependent induction of Nox4 and suppression of ANT2.
    Hubackova S; Kucerova A; Michlits G; Kyjacova L; Reinis M; Korolov O; Bartek J; Hodny Z
    Oncogene; 2016 Mar; 35(10):1236-49. PubMed ID: 25982278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of p53 with tumor suppressive and oncogenic signaling pathways to control cellular reactive oxygen species production.
    Ladelfa MF; Toledo MF; Laiseca JE; Monte M
    Antioxid Redox Signal; 2011 Sep; 15(6):1749-61. PubMed ID: 20919943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming growth factor-beta induces senescence in hepatocellular carcinoma cells and inhibits tumor growth.
    Senturk S; Mumcuoglu M; Gursoy-Yuzugullu O; Cingoz B; Akcali KC; Ozturk M
    Hepatology; 2010 Sep; 52(3):966-74. PubMed ID: 20583212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TGF-β signaling and epithelial-mesenchymal transition in cancer progression.
    Katsuno Y; Lamouille S; Derynck R
    Curr Opin Oncol; 2013 Jan; 25(1):76-84. PubMed ID: 23197193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factor-β: A therapeutic target for cancer.
    Haque S; Morris JC
    Hum Vaccin Immunother; 2017 Aug; 13(8):1741-1750. PubMed ID: 28575585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The inhibition of the epidermal growth factor (EGF) pathway enhances TGF-beta-induced apoptosis in rat hepatoma cells through inducing oxidative stress coincident with a change in the expression pattern of the NADPH oxidases (NOX) isoforms.
    Sancho P; Bertran E; Caja L; Carmona-Cuenca I; Murillo MM; Fabregat I
    Biochim Biophys Acta; 2009 Feb; 1793(2):253-63. PubMed ID: 18848961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epithelial-mesenchymal transition is regulated at post-transcriptional levels by transforming growth factor-β signaling during tumor progression.
    Saitoh M
    Cancer Sci; 2015 May; 106(5):481-8. PubMed ID: 25664423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subtoxic oxidative stress induces senescence in retinal pigment epithelial cells via TGF-beta release.
    Yu AL; Fuchshofer R; Kook D; Kampik A; Bloemendal H; Welge-Lüssen U
    Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):926-35. PubMed ID: 19171648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TGF-β signaling in cancer.
    Gu S; Feng XH
    Acta Biochim Biophys Sin (Shanghai); 2018 Oct; 50(10):941-949. PubMed ID: 30165534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming growth factor-beta in cancer and metastasis.
    Jakowlew SB
    Cancer Metastasis Rev; 2006 Sep; 25(3):435-57. PubMed ID: 16951986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The roles of TGF-β signaling in carcinogenesis and breast cancer metastasis.
    Imamura T; Hikita A; Inoue Y
    Breast Cancer; 2012 Apr; 19(2):118-24. PubMed ID: 22139728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factor-beta signaling in cancer invasion and metastasis.
    Leivonen SK; Kähäri VM
    Int J Cancer; 2007 Nov; 121(10):2119-24. PubMed ID: 17849476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nox4-derived ROS signaling contributes to TGF-β-induced epithelial-mesenchymal transition in pancreatic cancer cells.
    Hiraga R; Kato M; Miyagawa S; Kamata T
    Anticancer Res; 2013 Oct; 33(10):4431-8. PubMed ID: 24123012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interplay between TGF-β signaling and receptor tyrosine kinases in tumor development.
    Shi Q; Chen YG
    Sci China Life Sci; 2017 Oct; 60(10):1133-1141. PubMed ID: 29067649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dichotomous roles of TGF-β in human cancer.
    Huang JJ; Blobe GC
    Biochem Soc Trans; 2016 Oct; 44(5):1441-1454. PubMed ID: 27911726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and ex vivo vanadium antitumor activity in (TGF-β)-induced EMT. Synergistic activity with carboplatin and correlation with tumor metastasis in cancer patients.
    Petanidis S; Kioseoglou E; Domvri K; Zarogoulidis P; Carthy JM; Anestakis D; Moustakas A; Salifoglou A
    Int J Biochem Cell Biol; 2016 May; 74():121-34. PubMed ID: 26916505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming growth factor beta triggers two independent-senescence programs in cancer cells.
    Katakura Y; Nakata E; Miura T; Shirahata S
    Biochem Biophys Res Commun; 1999 Feb; 255(1):110-5. PubMed ID: 10082664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.